Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
A short-term treatment with buprenorphine prior to initiating treatment with naltrexone may
increase the proportion of heroin-dependent patients successfully inducted onto Vivitrol.
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
Alkermes, Inc.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Heroin Naloxone